Advances in developing novel therapeutic strategies for Alzheimer’s disease
Abstract Alzheimer’s Disease (AD), the most prevalent neurodegenerative disease of aging, affects one in eight older Americans. Nearly all drug treatments tested for AD today have failed to show any efficacy. There is a great need for therapies to prevent and/or slow the progression of AD. The major...
Main Authors: | Jiqing Cao, Jianwei Hou, Jing Ping, Dongming Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Molecular Neurodegeneration |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13024-018-0299-8 |
Similar Items
-
The “rights” of precision drug development for Alzheimer’s disease
by: Jeffrey Cummings, et al.
Published: (2019-08-01) -
An Overview of Novel Agents for Cervical Cancer Treatment by Inducing Apoptosis: Emerging Drugs Ongoing Clinical Trials and Preclinical Studies
by: Lei Liu, et al.
Published: (2021-07-01) -
Histone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies
by: Roberto Pili, et al.
Published: (2010-08-01) -
Drug candidates in clinical trials for Alzheimer’s disease
by: Shih-Ya Hung, et al.
Published: (2017-07-01) -
Anticancer drugs repurposed for Alzheimer’s disease: a systematic review
by: Antonio Ancidoni, et al.
Published: (2021-05-01)